Th17 Cell Plasticity and Functions in Cancer Immunity

Area of Science:

• Immunology
• Oncology
• Cellular Biology

Background:

• T helper 17 (Th17) cells are key players in immunity, producing IL-17 and other cytokines.
• Their established roles in inflammation and autoimmunity contrast with their debated function in cancer immunity.
• Th17 cells accumulate in tumors, but their prognostic impact varies across cancer types.

Purpose of the Study:

• To review the multifaceted role of Th17 cells in cancer immunity.
• To explore how the tumor microenvironment shapes Th17 cell plasticity and function.
• To discuss the implications of Th17 cell behavior for cancer progression and treatment.

Main Methods:

• Literature review of studies investigating Th17 cells in various cancer types.
• Analysis of cytokine profiles (e.g., IL-17, IFN-γ) associated with Th17 cells in tumors.
• Examination of Th17 cell plasticity and differentiation pathways within the tumor microenvironment.

Main Results:

• Th17 cells exhibit plasticity, adopting both pro-tumorigenic and anti-tumorigenic functions.
• Pro-tumorigenic effects include IL-17-mediated angiogenesis and immunosuppression.
• Anti-tumorigenic effects involve immune cell recruitment, CD8+ T cell activation, and conversion to IFN-γ-producing Th1 cells.

Conclusions:

• The tumor microenvironment critically dictates Th17 cell function in cancer.
• Th17 cells can be either detrimental or beneficial in cancer immunity, depending on context.
• Understanding Th17 cell plasticity is crucial for developing effective cancer immunotherapies.